Jan 16, 2026 12:55AM

Dec 19, 2025 02:32PM

Dec 19, 2025 02:24PM

Dec 10, 2025 08:20AM

Nov 11, 2025 03:27AM

Oct 27, 2025 02:55AM

Oct 17, 2025 04:23PM Genentech reports positive Phase III results for uveitic macular edema drug

Oct 16, 2025 11:49AM

Oct 2, 2025 05:00AM

Sep 23, 2025 02:20PM

Aug 25, 2025 02:31PM

Aug 8, 2025 04:02AM

Aug 8, 2025 04:00AM

Jul 18, 2025 11:45AM FDA rejects Genentech's Columvi combination for lymphoma treatment

Jun 20, 2025 11:48AM

May 12, 2025 10:49AM

Apr 28, 2025 03:25AM

Apr 16, 2025 10:16AM

Feb 13, 2025 12:13AM

Feb 11, 2025 06:00AM

Feb 4, 2025 11:46AM FDA Approves Genentech’s Susvimo as Delivery Treatment for the Leading Cause of Diabetes-Related Blindness

Feb 4, 2025 03:32AM

Jan 2, 2025 12:39PM

Dec 9, 2024 09:54AM

Nov 5, 2024 07:35AM

Sep 13, 2024 05:32AM

Sep 13, 2024 04:02AM

Sep 11, 2024 01:22PM Roche stock down 5% after disappointing drug trial data update

Aug 6, 2024 02:23AM

Jul 29, 2024 09:53AM

Jul 17, 2024 11:45AM

Jul 12, 2024 02:32AM

Jun 17, 2024 08:37AM

Jun 17, 2024 06:29AM

Jun 14, 2024 05:25AM Roche Holding (ROG:SW) (RHHBY) PT Raised to CHF305 at Bernstein SocGen Group

341,965 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All